IN2012MU00206A - - Google Patents

Download PDF

Info

Publication number
IN2012MU00206A
IN2012MU00206A IN206MU2012A IN2012MU00206A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A IN 206MU2012 A IN206MU2012 A IN 206MU2012A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A
Authority
IN
India
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN206MU2012 priority Critical patent/IN2012MU00206A/en
Priority to US13/745,010 priority patent/US9283270B2/en
Publication of IN2012MU00206A publication Critical patent/IN2012MU00206A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IN206MU2012 2012-01-20 2012-01-20 IN2012MU00206A (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (enExample) 2012-01-20 2012-01-20
US13/745,010 US9283270B2 (en) 2012-01-20 2013-01-18 Method for stabilization of biological molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (enExample) 2012-01-20 2012-01-20

Publications (1)

Publication Number Publication Date
IN2012MU00206A true IN2012MU00206A (enExample) 2013-08-09

Family

ID=48945734

Family Applications (1)

Application Number Title Priority Date Filing Date
IN206MU2012 IN2012MU00206A (enExample) 2012-01-20 2012-01-20

Country Status (2)

Country Link
US (1) US9283270B2 (enExample)
IN (1) IN2012MU00206A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102118071B1 (ko) 2012-11-21 2020-06-02 세럼 인스티튜트 오브 인디아 프라이비트 리미티드 박테리아 다당류를 고수율로 제조하는 방법
AU2016248452B2 (en) 2015-04-16 2018-05-31 Inventprise, Inc. Bordetella pertussis immunogenic vaccine compositions
US11305002B2 (en) 2015-06-09 2022-04-19 The Board Of Regents Of The University Of Oklahoma Compositions and treatments for Haemophilus influenzae
US10709758B2 (en) 2015-09-03 2020-07-14 The Board Of Regents Of The University Of Oklahoma Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin
PL3506935T3 (pl) * 2016-09-02 2024-06-10 Sanofi Pasteur, Inc. Szczepionka przeciwko Neisseria meningitidis
US11400162B2 (en) * 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
JP2020533299A (ja) * 2017-09-07 2020-11-19 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. キャリアタンパク質へのコンジュゲーションのための肺炎球菌多糖の製剤方法
CN107828360A (zh) * 2017-11-16 2018-03-23 西安长峰机电研究所 一种常温固化固体火箭发动机喷管结构粘接剂
CN112165951B (zh) 2018-04-16 2024-12-13 默克专利股份有限公司 用于改善热稳定性的蛋白质制剂添加剂
JOP20200214A1 (ar) * 2019-09-03 2021-03-03 Serum Institute Of India Pvt Ltd تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها
NL2023863B1 (en) * 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
WO2024233456A1 (en) 2023-05-05 2024-11-14 The Board Of Regents Of The University Of Oklahoma Variants of adrenomedullin (am) and adrenomedullin 2/intermedin (am2/imd) and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487632B1 (en) 1989-08-15 1998-03-04 Massachusetts Institute Of Technology Stabilized vaccine compositions
JPH09506777A (ja) 1993-12-21 1997-07-08 メルク エンド カンパニー インコーポレーテッド 熱安定性の水痘帯状疱疹ウイルス
EP0946193A1 (en) 1996-12-20 1999-10-06 Merck & Co., Inc. Stabilizers for lyophilized vaccines
CN1053590C (zh) 1998-10-19 2000-06-21 卫生部长春生物制品研究所 冻干甲型肝炎减毒活疫苗及其保护剂
CA2393298C (en) 1999-12-02 2011-02-01 Chiron Corporation Compositions and methods for stabilizing biological molecules upon lyophilization
JP5637848B2 (ja) * 2007-06-04 2014-12-10 ノバルティス アーゲー 髄膜炎ワクチンの製剤化
ATE553774T1 (de) * 2007-10-19 2012-05-15 Novartis Ag Meningokokkenimpfstoffformulierungen
BRPI0800357A2 (pt) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
MX2012010609A (es) * 2010-03-18 2012-10-03 Novartis Ag Vacunas adyuvadas para meningococos serogrupo b.

Also Published As

Publication number Publication date
US9283270B2 (en) 2016-03-15
US20130209503A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
BR122020002986A2 (enExample)
BR112014017635A2 (enExample)
BR112014020069A2 (enExample)
BR112014017614A2 (enExample)
BR112014017625A2 (enExample)
BR112014017659A2 (enExample)
BR112014017592A2 (enExample)
BR112014017607A2 (enExample)
BR112014017646A2 (enExample)
BR112014023589A2 (enExample)
BR112014017638A2 (enExample)
BR112013027865A2 (enExample)
BR112014017644A2 (enExample)
BR112014019239A2 (enExample)
BR112014017588A2 (enExample)
BR112014013184A8 (enExample)
BR112014017618A2 (enExample)
BR112014017647A2 (enExample)
BR112014017623A2 (enExample)
BR112014017652A2 (enExample)
BR112014017627A2 (enExample)
IN2012MU00206A (enExample)
BR112014017621A2 (enExample)
BR112014017641A2 (enExample)
BR112014017622A2 (enExample)